These findings align with recent evidence demonstrating independent associations between circulating leptin levels and hepatic fibrosis in individuals with BMI ≥ 25 kg/m2, suggesting that leptin’s role in liver pathophysiology extends beyond steatosis regulation to encompass fibrogenic processes [9]. The gene discussed is LEP; the disease is steatosis.